Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.

× No keyword cloud information.

5 in total

1. Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography.

Authors: Constantin Lapa; Rudolf A Werner; Ken Herrmann
Journal: Endocrine Date: 2015-06-18 Impact factor: 3.633

2. Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT.

Authors: Sandip Basu; Bhawna Sirohi; Shailesh V Shrikhande
Journal: Eur J Nucl Med Mol Imaging Date: 2014-05-27 Impact factor: 9.236

3. Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders.

Authors: Sandip Basu; Thomas C Kwee; Robert Gatenby; Babak Saboury; Drew A Torigian; Abass Alavi
Journal: Eur J Nucl Med Mol Imaging Date: 2011-06 Impact factor: 9.236

4. First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.

Authors: Ken Herrmann; Margret Schottelius; Constantin Lapa; Theresa Osl; Andreas Poschenrieder; Heribert Hänscheid; Katharina Lückerath; Martin Schreder; Christina Bluemel; Markus Knott; Ulrich Keller; Andreas Schirbel; Samuel Samnick; Michael Lassmann; Saskia Kropf; Andreas K Buck; Hermann Einsele; Hans-Juergen Wester; Stefan Knop
Journal: J Nucl Med Date: 2015-11-12 Impact factor: 10.057

5. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.

Authors: Daniel Kaemmerer; Tina Träger; Maike Hoffmeister; Bence Sipos; Merten Hommann; Jörg Sänger; Stefan Schulz; Amelie Lupp
Journal: Oncotarget Date: 2015-09-29

5 in total

3 in total

Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.

1. Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography.

2. Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT.

3. Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders.

4. First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.

5. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.

Review 1. The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?

2. C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4.

Review 3. Multimodal molecular imaging evaluation for early diagnosis and prognosis of cholangiocarcinoma.